On Cancer


381 Blog posts found

In the Lab

Prostate Cancer Drug Could Protect Bone Marrow from Damage Caused by Radiation

Researchers are working on a novel method for addressing a common complication of cancer treatment — bone marrow suppression.

Cross sections of mouse femurs showing bone marrow after radiation and no drug (left) and after radiation plus drug (right).


7 New Year’s Resolutions for Cancer Caregivers

Read our tips for managing your responsibilities as a caregiver.

Notebook sitting on desk with pen and glasses


4 Inspiring MSK Patients We Met This Year

Catch up with some of the patients we got to know in 2017.

Family of four posing on the boardwalk at the beach


How a Chicken Helped Solve the Mystery of Cancer

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.

A barred Plymouth Rock hen

Q & A

What Is Telemedicine and How Can It Help People with Cancer?

Meet Christian Otto, MSK’s Director of Teleoncology, who was most recently a senior scientist at NASA.

MSK’s Director of Teleoncology Christian Otto


The Unexpected Side Effects of Cancer Treatment

Learn about some lesser-known side effects from cancer treatment including falling caused by peripheral neuropathy, fatigue, hormone and sexual changes, and short-term memory problems (chemo brain).

Patient on left in chemotherapy infusion chair talking to nurse


A Look Back at MSK Monmouth’s First Year

Discover how MSK Monmouth is making an impact in Middletown, New Jersey.

An infographic describing MSK Monmouth's first year

In the News

Advances in Multiple Myeloma, Lymphoma, and Histiocytosis among Results Presented at 2017 ASH Meeting

The 2017 American Society of Hematology meeting featured news on promising advances in the treatment of blood cancers.

A crowd at the meeting of the American Society for Hematology

In the News

Breast Cancer Updates: Evaluating Prostate Cancer Drugs, Developing Better Predictive Tools, and Calculating Recurrence

Welcome sign at the San Antonio Breast Cancer Symposium

Q & A

Study Uncovers Genetic Reasons Why Some People Respond to Immunotherapy Better than Others

Immunotherapy drugs called checkpoint inhibitors have been a game changer for some people with cancer. But for most patients, these drugs have been disappointing. Researchers are trying to figure out why.

Model of a T cell receptor and an HLA-A white blood cell antigen bound to part of a virus